Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies.
about
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseTargeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
P2860
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@ast
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@en
type
label
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@ast
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@en
prefLabel
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@ast
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@en
P2093
P2860
P50
P356
P1476
Targeted tumor imaging of anti ...... gnosis of B-cell malignancies.
@en
P2093
Andrea Lorenzon
Gabriele Pozzato
Luis Núñez
Ruben Spretz
Sara Capolla
Sonia Zorzet
Stefania Biffi
P2860
P304
P356
10.2147/IJN.S78995
P407
P577
2015-06-22T00:00:00Z